Ameritas Investment Partners’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.3K | Buy |
+5,700
| New | +$21.6K | ﹤0.01% | 2618 |
|
|
2025
Q2 | – | Sell |
-6,300
| Closed | -$8K | – | 3285 |
|
|
2025
Q1 | $8K | Hold |
6,300
| – | – | ﹤0.01% | 2883 |
|
|
2024
Q4 | $20.5K | Hold |
6,300
| – | – | ﹤0.01% | 2626 |
|
|
2024
Q3 | $20.7K | Hold |
6,300
| – | – | ﹤0.01% | 2640 |
|
|
2024
Q2 | $26.8K | Hold |
6,300
| – | – | ﹤0.01% | 2488 |
|
|
2024
Q1 | $92.7K | Hold |
6,300
| – | – | ﹤0.01% | 1787 |
|
|
2023
Q4 | $60.6K | Buy |
6,300
+1,801
| +40% | +$12.4K | ﹤0.01% | 2051 |
|
|
2023
Q3 | $21K | Hold |
4,499
| – | – | ﹤0.01% | 2509 |
|
|
2023
Q2 | $24.1K | Hold |
4,499
| – | – | ﹤0.01% | 2469 |
|
|
2023
Q1 | $32.3K | Hold |
4,499
| – | – | ﹤0.01% | 2228 |
|
|
2022
Q4 | $26.4K | Hold |
4,499
| – | – | ﹤0.01% | 2434 |
|
|
2022
Q3 | $15K | Hold |
4,499
| – | – | ﹤0.01% | 2647 |
|
|
2022
Q2 | $13K | Hold |
4,499
| – | – | ﹤0.01% | 2750 |
|
|
2022
Q1 | $40K | Hold |
4,499
| – | – | ﹤0.01% | 2189 |
|
|
2021
Q4 | $72K | Hold |
4,499
| – | – | ﹤0.01% | 1896 |
|
|
2021
Q3 | $94K | Hold |
4,499
| – | – | ﹤0.01% | 1729 |
|
|
2021
Q2 | $121K | Hold |
4,499
| – | – | ﹤0.01% | 1604 |
|
|
2021
Q1 | $143K | Hold |
4,499
| – | – | 0.01% | 1433 |
|
|
2020
Q4 | $103K | Hold |
4,499
| – | – | ﹤0.01% | 1577 |
|
|
2020
Q3 | $113K | Buy |
4,499
+424
| +10% | +$11.6K | 0.01% | 1358 |
|
|
2020
Q2 | $114K | Hold |
4,075
| – | – | 0.01% | 1334 |
|
|
2020
Q1 | $24K | Hold |
4,075
| – | – | ﹤0.01% | 2073 |
|
|
2019
Q4 | $44K | Hold |
4,075
| – | – | ﹤0.01% | 2000 |
|
|
2019
Q3 | $52K | Hold |
4,075
| – | – | ﹤0.01% | 1864 |
|
|
2019
Q2 | $69K | Buy |
4,075
+821
| +25% | +$14.1K | ﹤0.01% | 1720 |
|
|
2019
Q1 | $59K | Hold |
3,254
| – | – | ﹤0.01% | 1788 |
|
|
2018
Q4 | $41K | Hold |
3,254
| – | – | ﹤0.01% | 1924 |
|
|
2018
Q3 | $70K | Hold |
3,254
| – | – | ﹤0.01% | 1783 |
|
|
2018
Q2 | $67K | Buy |
3,254
+501
| +18% | +$11.3K | ﹤0.01% | 1809 |
|
|
2018
Q1 | $69K | Hold |
2,753
| – | – | ﹤0.01% | 1727 |
|
|
2017
Q4 | $52K | Hold |
2,753
| – | – | ﹤0.01% | 1911 |
|
|
2017
Q3 | $52K | Hold |
2,753
| – | – | ﹤0.01% | 1876 |
|
|
2017
Q2 | $48K | Hold |
2,753
| – | – | ﹤0.01% | 1931 |
|
|
2017
Q1 | $51K | Buy |
+2,753
| New | +$53.1K | ﹤0.01% | 1825 |
|
Other funds holding MGNX
Ameritas Investment Partners's MGNX Position: Q2 2026 in Review
Ameritas Investment Partners opened a new position in MacroGenics (MGNX) in Q2 2026: 5,700 shares worth $26.3K. The stake represents ﹤0.01% of the portfolio and ranks #2618 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in MGNX as recently as Q1 2025.
Ameritas Investment Partners first reported a position in MGNX in Q1 2017 and has held it in 34 quarters since. The position peaked at $143K in Q1 2021. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.
- Ameritas Investment Partners held 5,700 shares of MacroGenics worth $26.3K as of Q2 2026.
- MacroGenics was a new Ameritas Investment Partners position in Q2 2026.
- MacroGenics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2618 holding.
- Ameritas Investment Partners first reported a position in MacroGenics in Q1 2017 and has held it in 34 quarters since.
- Ameritas Investment Partners's MacroGenics position peaked at $143K in Q1 2021.
- 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.